Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14940504 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL6542059 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL6542187 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL14940505 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL3764487 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL9246837 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL677609 | 1.00 | PDE4A (0.44) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL29808745 | 0.98 | PDE4A (0.43) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL19952979 | 0.82 | PDE4A (0.59) | PDE4ALMNAUSP2SLCO1B1OR51E2 | |
| SCHEMBL258100 | 0.82 | PDE4A (0.59) | PDE4ALMNAUSP2SLCO1B1OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842723-B2 | Ascorbic acid—natural sugar lactone esters for comprehensive skin and scalp care | BIODERM RESEARCH (US) | 2010-11-30 | — | — | US | claimed |
| US-20080287533-A1 | Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287533-A1 | Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care | GLA, COLGALT1, COL14A1 | PDE4A 3700/4885LMNA 927/4885USP2 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.